|
|
Profile
|
Delegates :
Kunihiro Nishimura, Ph.D. |
|
Incorporated :
April 1 , 2011 |
Paid in Capital :
10 Million yen |
Employees :
23 人 |
Address :
Mitsuyama Bldg., 4F 4-2-5, Hongo, Bunkyo-ku, TOKYO
〒113-0033
|
TEL/FAX :
+81-3-3868-2374 / +81-3-3868-2374 |
URL：
https://xcoo.jp/ |
Attachment :
|
Mission/Background :
Xcoo is a technology venture startup founded in 2011 with its mission to accelerate innovations in medical research, personalized medicine, genome drug discovery, and gene therapy through the appropriate use of state-of-the-art information technology. Xcoo develops, markets, and provides services for its software product Chrovis for genome medicine levering the cutting-edge natural language processing (NLP) and artificial intelligence (AI) technology. Xcoo provides technology and services that help accelerate advancement of genome medicine and precision medicine, a medical model to analyze and propose optimal treatment methods tailored to the individual patient. Xcoo will continue to contribute to the pharmaceutical and healthcare industry.
|
|
Technology & Business
|
・The total solution software for precision medicine Chrovis, is our main product. We implement services for cancer genome medical care that support genomic information analysis, knowledge database, report generation for patients, etc.. Xcoo currently teams with the University of Tokyo in its cancer genome medical research project.
・Chrovis maintains reliability equivalent to clinical testing standards, automatically analyzes individual genome information by next generation sequencing (NGS), and uses a knowledge database based on an enormous amount of information, in which we aim to provide reports directly linked to individualized diagnosis and treatment.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Chrovis
|
Service/Marketing
|
Chrovis is total solution software for genome medical treatment, which analyzes, defines, and reports data by the next generatio
|
By leveraging Chrovis, we contribute to the social implementation of genomic medicine.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
From genome analysis to their optimal treatment, as well as research to be used for drug selection and determination, all obtained from the somatic mutations and germline mutations of cancer patients, Xcoo, by using Chrovis, software for information analysis in genomic medicine, works on informatics on the genome medical research project lead by the University of Tokyo.
|
|
Hot news
|
In July 2019, Xcoo, Inc. was awarded the Minister‘s Award, Award for Academic Startups 2019 Program, by the Ministry of Education, Culture, Sports, Science and Technology, Japan, alongside the University of Japan.
|
|
Alliance strategy
|
We hope to collaborate in areas of development and management of mechanisms such as clinical sequence, knowledge database, natural language processing, and visualization, in which we may utilize our technology and experience.
|
|
|